Applicad Public Company Limited

APP signals a bright second half of 2026, accelerating revenue recognition from its backlog continuously, while benefiting from new car models gradually entering production lines in the third and fourth quarters. The company is also pushing forward with 3D metal printing to penetrate the personalized medical device market, partnering with Lerdsin Hospital to develop high-precision titanium parts. Chief Operating Officer Krikkrit Jearakamolchuen revealed that in the second quarter, the company was able to accelerate delivery of its order book well, although compared to the same period last year, there may be a difference due to the high revenue base from the previous year's low-volume production work for a subsidiary on a large-scale project. For the automotive business, APP remains strong in producing interior parts, especially plastic components such as seating systems and front consoles, supporting both internal combustion engine and electric vehicles. The company positions itself as a Tier 2 parts manufacturer, acting as a behind-the-scenes supporter for all Tier 1 manufacturers, reducing the risk of relying on a single customer and opening opportunities to supply parts to every car brand. In the medical business, the company is advancing 3D metal printing technology in collaboration with Lerdsin Hospital, a center for orthopedics, aiming to produce implantable devices from titanium metal, such as cranial plates and personalized medical devices requiring high precision. Additionally, the company continues to use a cross-product selling strategy to increase sales value from its existing customer base, while studying expansion into the defense industry and industrial automation systems, which are currently under discussion with partners and in the project development pipeline.